Skip to content
DataLookout
Menu

ONDINE-LCNCT07081464

Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 31 days later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 5 more changesShow less
    • Eligibility criteria expanded, about 7 words
    • Primary and study completion pushed from Oct 15, 2027 to Nov 15, 2027
    • Start date changed from estimate of Oct 15, 2025 to Nov 15, 2025
    • Study description revised
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Amplitude of the P300 wave (peak-to-baseline) recorded by high-resolution EEG during visual and auditory attention tasks.
Timeframe: 24 hours

Secondary (5)

Ratio of maximal pupil diameter during attention tasks to resting pupil diameter measured by pupillometry.
Functional connectivity parameters of the locus coeruleus measured by high-resolution EEG and 3T brain MRI diffusion imaging.
Scores of socio-adaptive behavior from the Vineland neuropsychological test (Vineland Adaptative Behavior Scales II, with scores ranging from 20 to 160; higher scores indicating better functioning).
Heart rate variability parameters from Holter ECG monitoring.
Structural connectivity parameters of the locus coeruleus measured by high-resolution EEG and 3T brain MRI diffusion imaging.

Arms and interventions

Subjects with severe Ondine syndrome (PHOX2B mutation with ≥ 27 alanine expansions)
Subjects with moderate Ondine syndrome (PHOX2B mutation with < 27 alanine expansions);

Other: MRI, EEG, Pupillometry

Sites

1 site in 1 country

  • Robert Debré HospitalParis, Ap-hp / DRCI, France